ClinVar Miner

Submissions for variant NM_000071.2(CBS):c.341C>T (p.Ala114Val) (rs121964964)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 13
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000200823 SCV000249676 likely pathogenic not provided 2020-10-20 criteria provided, single submitter clinical testing Reported in association with homocystinuria (Kozich et al., 1993; Sebastio et al., 1995; de Franchis et al., 1999; Kraus, et al., 1994; Meier et al., 2003; Moat et al., 2004; Katsushima et al., 2006; Urreizti et al., 2006; Pey et al., 2013); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Published functional studies have shown A114V leads to protein misfolding and instability compared to wild-type alleles (Kozich et al., 2010; Hznida et al., 2012); This variant is associated with the following publications: (PMID: 22612060, 7967489, 22267502, 22985361, 11359213, 25331909, 22069143, 20308073, 14722927, 10408774, 8353501, 28097321, 25087612, 12686134, 20506325, 20490928, 11748855, 20066033, 16307898, 16479318, 7762555, 31589614)
Soonchunhyang University Bucheon Hospital,Soonchunhyang University Medical Center RCV000490533 SCV000267240 likely pathogenic Classic homocystinuria 2016-03-18 criteria provided, single submitter reference population
Counsyl RCV000490533 SCV000678069 likely pathogenic Classic homocystinuria 2017-03-01 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000590659 SCV000695305 pathogenic Homocystinuria 2016-01-26 criteria provided, single submitter clinical testing Variant summary: The c.341C>T in CBS gene is a missense variant that involves a highly conserved nucleotide and 4/5 in silico tools predict deleterious outcome. The variant was observed in the large and broad cohorts of the ExAC ans ESP projects at an allele frequency of 0.027%. This frequency does not exceed the maximal expected allele frequency for a pathogenic variant in CBS (0.3%).suggesting this variant is not a common polymorphism. The variant has been reported in several affected individuals presented with features suggestive of Cystathionine--synthase deficiency. Functional studies performed in bacteria-based system showed slight misfolding of the recombinant protein and low enzymatic activity. The variant of interest has been reported as Pathogenic by several reputable databases/diagnostic centers.Taking together, the variant was classified as Pathogenic.
Genomic Research Center,Shahid Beheshti University of Medical Sciences RCV000490533 SCV000746328 pathogenic Classic homocystinuria 2017-12-03 criteria provided, single submitter clinical testing
Fulgent Genetics,Fulgent Genetics RCV000490533 SCV000893556 pathogenic Classic homocystinuria 2018-10-31 criteria provided, single submitter clinical testing
Invitae RCV000490533 SCV000956328 pathogenic Classic homocystinuria 2020-10-28 criteria provided, single submitter clinical testing This sequence change replaces alanine with valine at codon 114 of the CBS protein (p.Ala114Val). The alanine residue is moderately conserved and there is a small physicochemical difference between alanine and valine. This variant is present in population databases (rs121964964, ExAC 0.03%). This variant has been observed in an individual with low cystathionine- beta synthase enzyme activity, findings that are highly specific for homocystinuria due to cystathionine-beta synthase (CBS) deficiency (PMID: 8353501). It has also been reported in individuals with a clinical diagnosis of cystathionine-beta synthase deficiency (PMID: 7762555) ClinVar contains an entry for this variant (Variation ID: 119). Experimental studies have shown that this missense change disrupts CBS protein activity (PMID: 20490928, 22612060, 22267502, 22069143, 20506325). For these reasons, this variant has been classified as Pathogenic.
Centre for Mendelian Genomics,University Medical Centre Ljubljana RCV000490533 SCV001369940 pathogenic Classic homocystinuria 2019-08-16 criteria provided, single submitter clinical testing This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PS1,PS3,PM2,PM5.
Institute of Human Genetics, University of Leipzig Medical Center RCV000490533 SCV001443030 pathogenic Classic homocystinuria 2020-03-01 criteria provided, single submitter clinical testing Review of the variants reported in Reuter et al., 2017, PMID: 28097321: PS3,PS4_moderate,PM2,PM3,PP3
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen RCV000200823 SCV001448148 pathogenic not provided 2020-10-23 criteria provided, single submitter clinical testing
Baylor Genetics RCV000490533 SCV001524388 likely pathogenic Classic homocystinuria 2020-09-11 criteria provided, single submitter clinical testing This variant was determined to be likely pathogenic according to ACMG Guidelines, 2015 [PMID:25741868].
Mayo Clinic Laboratories, Mayo Clinic RCV000200823 SCV001713878 pathogenic not provided 2020-05-21 criteria provided, single submitter clinical testing PS3, PS4_moderate, PM3_verystrong, PP3, PP4
OMIM RCV000000140 SCV000020283 pathogenic Homocystinuria, pyridoxine-responsive 1993-06-01 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.